The biotechnology industry is still a growth industry. Investing in an ETF gives me exposure to an industry I don't fully understand. The two major ETFs in the industry have different portfolio ...

In the world of biotechnology investing, companies often struggle to bring new drugs to market. Developing treatments for rare diseases can be incredibly expensive, and because these conditions affect ...

The biotech sector staged a robust comeback in 2025, with the Nasdaq Biotechnology Index climbing 33.8%. Although concerns about potential high tariffs initially hurt the industry, sentiment among ...

Earlier this week, the congressionally-mandated National Security Commission on Emerging Biotechnology released its major report, titled “Charting the Future of Biotechnology.” The bipartisan and ...